420 related articles for article (PubMed ID: 25350088)
1. Multivoxel proton magnetic resonance spectroscopy of inflammatory and neoplastic lesions of the canine brain at 3.0 T.
Stadler KL; Ober CP; Feeney DA; Jessen CR
Am J Vet Res; 2014 Nov; 75(11):982-9. PubMed ID: 25350088
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of intracranial neoplasia and noninfectious meningoencephalitis in dogs by use of short echo time, single voxel proton magnetic resonance spectroscopy at 3.0 Tesla.
Carrera I; Richter H; Beckmann K; Meier D; Dennler M; Kircher PR
Am J Vet Res; 2016 May; 77(5):452-62. PubMed ID: 27111012
[TBL] [Abstract][Full Text] [Related]
3. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
[TBL] [Abstract][Full Text] [Related]
4. Preoperative grading of intracranial meningioma by magnetic resonance spectroscopy (1H-MRS).
Lin MC; Li CZ; Hsieh CC; Hong KT; Lin BJ; Lin C; Tsai WC; Lee CH; Lee MG; Chung TT; Tang CT; Ju DT; Ma HI; Liu MY; Chen YH; Hueng DY
PLoS One; 2018; 13(11):e0207612. PubMed ID: 30452483
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.
Harada M; Tanouchi M; Nishitani H; Miyoshi H; Bandou K; Kannuki S
Jpn J Cancer Res; 1995 Mar; 86(3):329-32. PubMed ID: 7744704
[TBL] [Abstract][Full Text] [Related]
6. Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
Poptani H; Gupta RK; Roy R; Pandey R; Jain VK; Chhabra DK
AJNR Am J Neuroradiol; 1995 Sep; 16(8):1593-603. PubMed ID: 7502961
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro.
Xu YJ; Cui Y; Li HX; Shi WQ; Li FY; Wang JZ; Zeng QS
Magn Reson Imaging; 2016 Oct; 34(8):1121-7. PubMed ID: 27215950
[TBL] [Abstract][Full Text] [Related]
8. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
Balos DR; Gavrilović S; Lavrnić S; Vasić B; Macvanski M; Damjanović D; Opinćal TS
Vojnosanit Pregl; 2013 Jul; 70(7):637-44. PubMed ID: 23984611
[TBL] [Abstract][Full Text] [Related]
11. Multivoxel proton magnetic resonance spectroscopy in heat stroke.
Li J; Zhang XY; Wang B; Zou ZM; Li HF; Wang PY; Xia JK
Clin Radiol; 2015 Jan; 70(1):37-41. PubMed ID: 25443777
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy differentiates tumefactive demyelinating lesions from gliomas.
Ikeguchi R; Shimizu Y; Abe K; Shimizu S; Maruyama T; Nitta M; Abe K; Kawamata T; Kitagawa K
Mult Scler Relat Disord; 2018 Nov; 26():77-84. PubMed ID: 30237108
[TBL] [Abstract][Full Text] [Related]
13. Major Metabolite Levels of Preoperative Proton Magnetic Resonance Sectroscopy and Intraoperative Fluorescence Intensity in Glioblastoma.
Tian HL; Zu YL; Wang CC; Lin T; Guo ZT; Jiang B; Yin X; Guo WQ; Wang ZG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):511-517. PubMed ID: 28877829
[TBL] [Abstract][Full Text] [Related]
14. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
16. Proton MR spectroscopy of tumefactive demyelinating lesions.
Saindane AM; Cha S; Law M; Xue X; Knopp EA; Zagzag D
AJNR Am J Neuroradiol; 2002 Sep; 23(8):1378-86. PubMed ID: 12223381
[TBL] [Abstract][Full Text] [Related]
17. Low-grade gliomas and focal cortical developmental malformations: differentiation with proton MR spectroscopy.
Vuori K; Kankaanranta L; Häkkinen AM; Gaily E; Valanne L; Granström ML; Joensuu H; Blomstedt G; Paetau A; Lundbom N
Radiology; 2004 Mar; 230(3):703-8. PubMed ID: 14739313
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
Wang Q; Zhang H; Zhang J; Wu C; Zhu W; Li F; Chen X; Xu B
Eur Radiol; 2016 Aug; 26(8):2670-84. PubMed ID: 26471274
[TBL] [Abstract][Full Text] [Related]
19. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
20. The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas.
Yao R; Cheng A; Liu M; Zhang Z; Jin B; Yu H
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):269-276. PubMed ID: 33346568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
